Profilo
Boris Fain is the founder of two companies.
He founded Diagnose Early, Inc. and InterX, Inc. At Diagnose Early, Inc., he held no specific title.
At InterX, Inc., he held the titles of Chief Science Officer and Chief Technology Officer, but is no longer active in those roles.
Posizioni attive di Boris Fain
| Società | Posizione | Inizio |
|---|---|---|
InterX, Inc.
 InterX, Inc. Pharmaceuticals: MajorHealth Technology Part of NeoTX Therapeutics Ltd., InterX, Inc. develops cancer therapies. The company is based in Walnut Creek, CA. The company was founded by Roger David Kornberg, Boris Fain. The CEO is Paul Marinelli. InterX was acquired by NeoTX Therapeutics Ltd. on May 12, 2022. | Fondatore | - |
Precedenti posizioni note di Boris Fain
| Società | Posizione | Fine |
|---|---|---|
Diagnose Early, Inc.
 Diagnose Early, Inc. Pharmaceuticals: MajorHealth Technology Diagnose Early, Inc. is a company that specializes in non-invasive breath and biometric testing. The company is based in Newark, CA. The company has developed a proprietary breath analysis technology and an AI health data platform that allows users to collect their health data in one place. The company's breath testing technology is designed to provide non-invasive detection of toxins and other chemicals that may pose a health threat in minutes. Diagnose Early was founded by Boris Fain, Chris Wheeler, and John Cunniff. Chris Wheeler has been the CEO since incorporation. | Fondatore | - |
Esperienze
Posizioni ricoperte
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 2 |
|---|---|
InterX, Inc.
InterX, Inc. Pharmaceuticals: MajorHealth Technology Part of NeoTX Therapeutics Ltd., InterX, Inc. develops cancer therapies. The company is based in Walnut Creek, CA. The company was founded by Roger David Kornberg, Boris Fain. The CEO is Paul Marinelli. InterX was acquired by NeoTX Therapeutics Ltd. on May 12, 2022. | Health Technology |
Diagnose Early, Inc.
Diagnose Early, Inc. Pharmaceuticals: MajorHealth Technology Diagnose Early, Inc. is a company that specializes in non-invasive breath and biometric testing. The company is based in Newark, CA. The company has developed a proprietary breath analysis technology and an AI health data platform that allows users to collect their health data in one place. The company's breath testing technology is designed to provide non-invasive detection of toxins and other chemicals that may pose a health threat in minutes. Diagnose Early was founded by Boris Fain, Chris Wheeler, and John Cunniff. Chris Wheeler has been the CEO since incorporation. | Health Technology |
- Borsa valori
- Insiders
- Boris Fain